100%, Zurich, fixed-term
The Research Group for Peptide-Based Drug Discovery (Prof. Nathalie M. Grob) at ETH Zürich, in collaboration with Novo Nordisk in Copenhagen, Denmark, is seeking an exceptional and highly motivated PhD candidate for a joint project. We are recruiting a full-time (100%) PhD Student with a strong interest in peptide chemistry, mass spectrometry, and modern drug discovery to establish an innovative platform for peptide drug discovery.
Peptides are recognized as privileged modalities for the development of new therapeutic strategies. The discovery of bioactive peptides aimed at addressing unexploited targets and offering alternative therapeutic strategies on established disease pathways represents a fundamental challenge. This project emphasizes the development of novel technologies for hit identification and validation, with a focus on achieving high experimental throughput and success rates.
The four-year project is co-funded by Novo Nordisk and will be supervised by Prof. Nathalie Grob (ETHZ) in cooperation with Novo Nordisk, providing a unique opportunity to work at the intersection of academia and industry. This project leverages cutting-edge technology to make a real-world impact in peptide drug discovery. Short research visits (3 months) at the Novo Nordisk research site in Copenhagen and access to high-throughput instrumentation are planned throughout the project. Candidates with prior experience in peptide synthesis, mammalian tissue culture, and mass spectrometry will find this advantageous.
To contribute to the project's success, the candidate will integrate into a multidisciplinary team that effectively combines independent work with collaborative discussions. Responsibilities will include:
The ideal candidate will hold a recently completed MSc degree or equivalent in Chemistry, Pharmacy, Pharmaceutical Sciences, Chemical Biology, Cellular Biology, or related disciplines. Relevant experience in several of the following areas is preferred:
The successful applicant will possess a genuine passion for science and collaboration, coupled with a strong motivation and intrinsic interest in drug discovery and development. Effective communication skills in English are essential as the working language in a multidisciplinary environment.
The candidate must be available to start the project by 01 October 2025. Additionally, it is required that the candidate has authorization to work in Switzerland and can travel to Denmark for short-term projects (under 3 months) without the need for additional permits.
Join a vibrant research community in a dynamic and innovative academic environment.
In line with our values, ETH Zurich fosters an inclusive culture. We promote equality of opportunity, value diversity, and create a working and learning environment that respects the rights and dignity of all staff and students. Visit our Equal Opportunities and Diversity website to learn more about how we ensure a fair and open environment that allows everyone to thrive.
Apply online using the form below. Only applications matching the job profile will be considered.
For any questions regarding the position, please contact Prof. Nathalie M. Grob at Tel [] or email [].
ETH Zurich is one of the world’s leading universities specializing in science and technology, recognized for its outstanding education, pioneering research, and direct transfer of knowledge to society. With over 30,000 individuals from more than 120 countries, our university promotes independent thinking and fosters an environment that inspires excellence. Situated in the heart of Europe while forming global connections, we work collaboratively to develop solutions for today’s and tomorrow's challenges.
Location : Zürich
Country : Switzerland